A comprehensive view of inhalers/sprays/vaporizers. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

TFF Pharmaceuticals Q1 highlights include partnering with Catalent to expand thin film freezing applications to develop biologic drugs; Phase 2 trials of inhaled Voriconazole powder and Tacrolimus powder started, with data expected later this year

Biopharmaceutical firm Savara reports Q1 R&D expenses down 25.1% from a year ago to US$5.7M due to wind-down of inhaled vancomycin development program; Phase 3 inhaled biologic molgramostim/eFlow nebulizer trial remains on-track for a 20-month enrollment

FDA approves Alembic Pharmaceuticals’ ANDA for arformoterol tartrate inhalation solution, 15 mcg/2 mL unit-dose to treat chronic obstructive pulmonary bronchoconstriction; drug is therapeutic equivalent of Sunovion Pharmaceuticals’ Brovana

FDA gives breakthrough therapy designation to Zambon’s inhaled colistimethate sodium powder to treat pulmonary exacerbations in non-cystic fibrosis bronchiectasis; treatment uses adaptive aerosol delivery battery-powered I-neb nebulizer

Stevanato named exclusive manufacturer of Owen Mumford’s Aidaptus two-step, single-use auto-injector that automatically adapts to fill volume; device joins Stevanato’s portfolio of pen injector, auto-injector, inhaler, wearable delivery system

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count